盘点2009 年, 心律失常领域亮点纷呈:(1) Record—AF 注册研究显示心房颤动(简称房颤)
室率与节律控制疗效相当.(2) APAF2, ThermoCoolAF 等研究进一步验证了导管消融治疗房颤的 …

Atrial and ventricular arrhythmias are associated with substantial morbidity and mortality and
thus are a significant economic burden for healthcare systems. Currently available …

Introduction Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical
practice and rhythm control using pharmacological agents is required in selected patients …

In recent years, a major development in the treatment of atrial fibrillation (AF) is the use of
catheter ablation, and a significant number of patients may benefit from this mode of therapy …

Since deuterium replacement has a potential to modulate pharmacodynamics,
pharmacokinetics and toxicity, we developed deuterated dronedarone; poyendarone, and …

Epidemiological studies show that atrial fibrillation (AF) is associated with a doubling of
mortality, even after adjustment for confounders. AF can be asymptomatic, but this does not …

Introduction: Significant progress has recently been made in the pharmacological treatment
of arrhythmias. This concerns mainly atrial fibrillation, which affects millions of patients …

Disclosed are methods to treat patients with AFib by monitoring their heart rhythm to
determine the presence and/or the number of episodes of long duration AFib, and optionally …

Atrial fibrillation (AF) and heart failure (HF) frequently occur together, and their coexistence
is associated with a poor prognosis. AF and HF share risk factors, but their relationship …

Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia in clinical practice
associated with significant morbidity and mortality. With the growing number of the affected …